A citation-based method for searching scientific literature

John H Krystal, Chadi G Abdallah, Gerard Sanacora, Dennis S Charney, Ronald S Duman. Neuron 2019
Times Cited: 134



Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
Times Cited: 2186




List of shared articles



Times cited


Perspectives for therapy of treatment-resistant depression.
Mariusz Papp, Wiesław Jerzy Cubala, Lukasz Swiecicki, Adrian Newman-Tancredi, Paul Willner. Br J Pharmacol 2022
4

Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.
Wei Yao, Qianqian Cao, Shilin Luo, Lujuan He, Chun Yang, Jiaxu Chen, Qi Qi, Kenji Hashimoto, Ji-Chun Zhang. Mol Psychiatry 2022
6


Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine.
Li Ma, Jiancheng Zhang, Yuko Fujita, Youge Qu, Jiajing Shan, Xiayun Wan, Xingming Wang, Tamaki Ishima, Kenta Kobayashi, Long Wang,[...]. Transl Psychiatry 2022
4

Imaging the effect of ketamine on synaptic density (SV2A) in the living brain.
Sophie E Holmes, Sjoerd J Finnema, Mika Naganawa, Nicole DellaGioia, Daniel Holden, Krista Fowles, Margaret Davis, Jim Ropchan, Paul Emory, Yunpeng Ye,[...]. Mol Psychiatry 2022
1

Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1.
Kelly Smart, Ming-Qiang Zheng, Hazem Ahmed, Hanyi Fang, Yuping Xu, Lisheng Cai, Daniel Holden, Michael Kapinos, Ahmed Haider, Zachary Felchner,[...]. J Cereb Blood Flow Metab 2022
0

Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Anya Ragnhildstveit, Matthew Slayton, Laura Kate Jackson, Madeline Brendle, Sachin Ahuja, Willis Holle, Claire Moore, Kellie Sollars, Paul Seli, Reid Robison. Brain Sci 2022
0

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression.
Xingming Wang, Jianjun Yang, Kenji Hashimoto. Neurosci Biobehav Rev 2022
0

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant.
Songbai Xu, Xiaoxiao Yao, Bingjin Li, Ranji Cui, Cuilin Zhu, Yao Wang, Wei Yang. Front Pharmacol 2022
0


Efficacy of anticonvulsant ethosuximide for major depressive disorder: a randomized, placebo-control clinical trial.
Kai Zhang, Gang Jia, Lei Xia, Jianbin Du, Guanchen Gai, Zhiqiang Wang, Leiming Cao, Fuquan Zhang, Rui Tao, Huanzhong Liu,[...]. Eur Arch Psychiatry Clin Neurosci 2021
3

Ketamine: A tale of two enantiomers.
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
36

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi. Pharmacol Rev 2021
34

Sex- and stress-dependent effects of a single injection of ketamine on open field and forced swim behavior.
Paul J Fitzgerald, Savannah K Kounelis-Wuillaume, Ali Gheidi, Jonathan D Morrow, Joanna L Spencer-Segal, Brendon O Watson. Stress 2021
5

The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression.
Conor W McDonnell, Fionn Dunphy-Doherty, Jennifer Rouine, Massimiliano Bianchi, Neil Upton, Ewa Sokolowska, Jack A Prenderville. Front Psychiatry 2021
2

Ketamine and the Future of Rapid-Acting Antidepressants.
Lace M Riggs, Todd D Gould. Annu Rev Clin Psychol 2021
9

Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels.
Bonnie Robinson, Qiang Gu, Jyotshna Kanungo. Chem Res Toxicol 2021
1

Neurobiology of the Rapid-Acting Antidepressant Effects of Ketamine: Impact and Opportunities.
Ryota Shinohara, George K Aghajanian, Chadi G Abdallah. Biol Psychiatry 2021
9

Ketamine for depression.
Luke A Jelen, James M Stone. Int Rev Psychiatry 2021
2

Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons.
Chidiebere M Iro, Rami Hamati, Mostafa El Mansari, Pierre Blier. Int J Neuropsychopharmacol 2021
1

Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology.
Mark David Tricklebank, Trevor W Robbins, Camilla Simmons, Erik H F Wong. Psychopharmacology (Berl) 2021
3

Pharmacotherapeutic Strategies and New Targets in OCD.
Christopher Pittenger. Curr Top Behav Neurosci 2021
1

Distinct trajectories of antidepressant response to intravenous ketamine.
Brittany O'Brien, Marijn Lijffijt, Jaehoon Lee, Ye Sil Kim, Allison Wells, Nicholas Murphy, Nithya Ramakrishnan, Alan C Swann, Sanjay J Mathew. J Affect Disord 2021
4



Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One?
Ridge G Weston, Paul J Fitzgerald, Brendon O Watson. Front Psychiatry 2021
3

Combining Ketamine and Internet-Based Cognitive Behavioral Therapy for the Treatment of Posttraumatic Stress Disorder: Protocol for a Randomized Controlled Trial.
Aaron Emile Philipp-Muller, Taras Reshetukha, Gustavo Vazquez, Roumen Milev, Dawn Armstrong, Jasleen Jagayat, Nazanin Alavi. JMIR Res Protoc 2021
2

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study.
Raquel Pascual-Antón, Arantxa Blasco-Serra, Emma Muñoz-Moreno, Fuencisla Pilar-Cuéllar, Emilio Garro-Martínez, Eva Florensa-Zanuy, Xavier López-Gil, Víctor M Campa, Guadalupe Soria, Albert Adell. Brain Struct Funct 2021
2

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors.
Vesna Lazarevic, Yunting Yang, Ivana Flais, Per Svenningsson. Mol Psychiatry 2021
9

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants.
Okko Alitalo, Roosa Saarreharju, Ioline D Henter, Carlos A Zarate, Samuel Kohtala, Tomi Rantamäki. Prog Neurobiol 2021
1

Ketamine in depression and electroconvulsive therapy.
Irene Rozet. Curr Opin Anaesthesiol 2021
1


Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Kasper B Hansen, Lonnie P Wollmuth, Derek Bowie, Hiro Furukawa, Frank S Menniti, Alexander I Sobolevsky, Geoffrey T Swanson, Sharon A Swanger, Ingo H Greger, Terunaga Nakagawa,[...]. Pharmacol Rev 2021
29

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.
Johanna Louise Keeler, Janet Treasure, Mario F Juruena, Carol Kan, Hubertus Himmerich. Nutrients 2021
4

Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.
Anya Ragnhildstveit, Laura Kate Jackson, Sarah Cunningham, Linda Good, Quinn Tanner, Matthew Roughan, Patricia Henrie-Barrus. Front Psychiatry 2021
5

Repurposing Potential of Ketamine: Opportunities and Challenges.
C S Gautam, Sonia S Mahajan, Jatin Sharma, Harmanjit Singh, Jagjit Singh. Indian J Psychol Med 2020
13

Ketamine: Leading us into the future for development of antidepressants.
Flavia R Carreno, Daniel J Lodge, Alan Frazer. Behav Brain Res 2020
7

S-ketamine induces acute changes in the proteome of the mouse amygdala.
Mhd Rami Al Shweiki, Patrick Oeckl, Petra Steinacker, Peggy Barschke, Christopher Pryce, Cornelia Dorner-Ciossek, Carlos Schönfeldt-Lecuona, Bastian Hengerer, Markus Otto. J Proteomics 2020
3

A historical review of antidepressant effects of ketamine and its enantiomers.
Yan Wei, Lijia Chang, Kenji Hashimoto. Pharmacol Biochem Behav 2020
60

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1.
Kai Zhang, Chun Yang, Lijia Chang, Akemi Sakamoto, Toru Suzuki, Yuko Fujita, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan,[...]. Transl Psychiatry 2020
30

(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Rei Yokoyama, Momoko Higuchi, Wataru Tanabe, Shinji Tsukada, Megumi Naito, Takumi Yamaguchi, Lu Chen, Atsushi Kasai, Kaoru Seiriki, Takanobu Nakazawa,[...]. Pharmacol Biochem Behav 2020
16